3,534
Views
45
CrossRef citations to date
0
Altmetric
Review

Progress and prospects for blood-stage malaria vaccines

Pages 765-781 | Received 09 Nov 2015, Accepted 11 Jan 2016, Published online: 03 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kazutoyo Miura, Mayumi Tachibana, Eizo Takashima, Masayuki Morita, Bernard N. Kanoi, Hikaru Nagaoka, Minami Baba, Motomi Torii, Tomoko Ishino & Takafumi Tsuboi. (2019) Malaria transmission-blocking vaccines: wheat germ cell-free technology can accelerate vaccine development. Expert Review of Vaccines 18:10, pages 1017-1027.
Read now
Edward H. Ntege, Eizo Takashima, Masayuki Morita, Hikaru Nagaoka, Tomoko Ishino & Takafumi Tsuboi. (2017) Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates. Expert Review of Vaccines 16:8, pages 769-779.
Read now

Articles from other publishers (43)

Kazutoyo Miura, Ababacar Diouf, Michael P. Fay, Jordan R. Barrett, Ruth O. Payne, Ally I. Olotu, Angela M. Minassian, Sarah E. Silk, Simon J. Draper & Carole A. Long. (2023) Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies. Malaria Journal 22:1.
Crossref
Lode Schuerman & Christian Ockenhouse. 2023. Plotkin's Vaccines. Plotkin's Vaccines 617 628.e7 .
Mojtaba Azimi-Resketi, Saeed Heydaryan, Niloufar Kumar, Azin Takalou, Reza Esmaeelzadeh Dizaji, Bahman Noroozi Gorgani & Morteza Shams. (2022) Computational Clues of Immunogenic Hotspots in Plasmodium falciparum Erythrocytic Stage Vaccine Candidate Antigens: In Silico Approach. BioMed Research International 2022, pages 1-21.
Crossref
Maya Aleshnick, Melina Florez-Cuadros, Thomas Martinson & Brandon K. Wilder. (2022) Monoclonal antibodies for malaria prevention. Molecular Therapy 30:5, pages 1810-1821.
Crossref
Aroosa Younis Nadeem, Adeeb Shehzad, Salman Ul Islam, Ebtesam A. Al-Suhaimi & Young Sup Lee. (2022) Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy. Vaccines 10:5, pages 713.
Crossref
Md. Tanjir Islam, Mei-Fong Ho, Ummey J. Nahar, Ahmed O. Shalash, Prashamsa Koirala, Waleed M. Hussein, Danielle I. Stanisic, Michael F. Good, Mariusz Skwarczynski & Istvan Toth. (2022) Investigation of liposomal self-adjuvanting peptide epitopes derived from conserved blood-stage Plasmodium antigens. PLOS ONE 17:3, pages e0264961.
Crossref
Clemente F. Arias, Francisco J. Acosta & Cristina Fernandez-Arias. (2022) Killing the competition: a theoretical framework for liver-stage malaria. Open Biology 12:3.
Crossref
Titus Okello Orwa, Rachel Waema Mbogo & Livingstone Serwadda Luboobi. (2022) Optimal control analysis of hepatocytic-erythrocytic dynamics of Plasmodium falciparum malaria. Infectious Disease Modelling 7:1, pages 82-108.
Crossref
Su-Hwa Lee, Ki-Back Chu, Hae-Ji Kang & Fu-Shi Quan. (2022) Protection and Alleviated Inflammation Induced by Virus-like Particle Vaccines Containing Plasmodium berghei MSP-8, MSP-9 and RAP1. Vaccines 10:2, pages 203.
Crossref
DwiAri Santi Putri, Erma Sulistyaningsih, IrawanFajar Kusuma & Rosita Dewi. (2022) Total leukocyte count in Rattus norvegicus after duffy binding-like 2β- Plasmodium falciparum erythrocyte membrane protein 1 recombinant protein injection: The way to a peptide-based malaria vaccine development . Biomolecular and Health Science Journal 5:2, pages 71.
Crossref
Claire Aguttu, Brenda Apio Okech, Ambrose Mukisa & George William Lubega. (2021) Screening and characterization of hypothetical proteins of Plasmodium falciparum as novel vaccine candidates in the fight against malaria using reverse vaccinology. Journal of Genetic Engineering and Biotechnology 19:1.
Crossref
Brian Greenwood, Matthew Cairns, Mike Chaponda, R. Matthew Chico, Alassane Dicko, Jean-Bosco Ouedraogo, Kamija S. Phiri, Feiko O. ter Kuile & Daniel Chandramohan. (2021) Combining malaria vaccination with chemoprevention: a promising new approach to malaria control. Malaria Journal 20:1.
Crossref
Ian C. Michelow, Sangshin Park, Shu-Whei Tsai, Bonnie Rayta, Charisse Flerida A. Pasaje, Sara Nelson, Angela M. Early, Anne P. Frosch, George Ayodo, Dipak K. Raj, Christina E. Nixon, Christian P. Nixon, Sunthorn Pond-Tor, Jennifer F. Friedman, Michal Fried, Patrick E. Duffy, Karine G. Le Roch, Jacquin C. Niles & Jonathan D. Kurtis. (2021) A newly characterized malaria antigen on erythrocyte and merozoite surfaces induces parasite inhibitory antibodies. Journal of Experimental Medicine 218:9.
Crossref
Xue Zheng, Jingjing Zhang, Chenghui Lu, Yonglong Zhuang & Xuecheng Zhang. (2021) Rational Design of Peptide Inhibitor Against Amyloidogenesis-Correlated Membrane Disruption by Merozoite Surface Protein 2. International Journal of Peptide Research and Therapeutics 27:3, pages 1657-1666.
Crossref
Alexandra C. Willcox, Alex S. Huber, Ababacar Diouf, Jordan R. Barrett, Sarah E. Silk, David Pulido, Lloyd D.W. King, Daniel G.W. Alanine, Angela M. Minassian, Mahamadou Diakite, Simon J. Draper, Carole A. Long & Kazutoyo Miura. (2021) Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies. Cell Reports Medicine 2:7, pages 100326.
Crossref
José Manuel Lozano, Zully Rodríguez Parra, Salvador Hernández-Martínez, Maria Fernanda Yasnot-Acosta, Angela Patricia Rojas, Luz Stella Marín-Waldo & Juan Edilberto Rincón. (2021) The Search of a Malaria Vaccine: The Time for Modified Immuno-Potentiating Probes. Vaccines 9:2, pages 115.
Crossref
Bernard N. Kanoi, Hikaru Nagaoka, Masayuki Morita, Takafumi Tsuboi & Eizo Takashima. (2021) Leveraging the wheat germ cell-free protein synthesis system to accelerate malaria vaccine development. Parasitology International 80, pages 102224.
Crossref
Kakou G. Aka, Dipomin F. Traoré, André B. Sagna, Dounin D. Zoh, Serge B. Assi, Bertin N’cho Tchiekoi, Akré M. Adja, Franck Remoue & Anne Poinsignon. (2020) Pattern of antibody responses to Plasmodium falciparum antigens in individuals differentially exposed to Anopheles bites. Malaria Journal 19:1.
Crossref
Puthupparampil V. Scaria, Beth B. Chen, Christopher G. Rowe, Nada Alani, Olga V. Muratova, Emma K. Barnafo, Lynn E. Lambert, Irfan U. Zaidi, Andrew Lees, Kelly M. Rausch, David L. Narum & Patrick E. Duffy. (2020) Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230. Vaccine 38:34, pages 5480-5489.
Crossref
Prateek Bhardwaj, Eshant Bhatia, Shivam Sharma, Nadim Ahamad & Rinti Banerjee. (2020) Advancements in prophylactic and therapeutic nanovaccines. Acta Biomaterialia 108, pages 1-21.
Crossref
Jerome Nyhalah Dinga, Stephanie Numenyi Perimbie, Stanley Dobgima Gamua, Francis N. G. Chuma, Dieudonné Lemuh Njimoh, Appolinaire Djikeng, Roger Pelle & Vincent P. K. Titanji. (2020) Analysis of the Role of TpUB05 Antigen from Theileria parva in Immune Responses to Malaria in Humans Compared to Its Homologue in Plasmodium falciparum the UB05 Antigen. Pathogens 9:4, pages 271.
Crossref
Antje Blank, Kristin Fürle, Anja Jäschke, Gerd Mikus, Monika Lehmann, Johannes Hüsing, Kirsten Heiss, Thomas Giese, Darrick Carter, Ernst Böhnlein, Michael Lanzer, Walter E. Haefeli & Hermann Bujard. (2020) Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial. npj Vaccines 5:1.
Crossref
Nikunj Tandel, Devang Trivedi, Aditi Mohan Krishnan & Sarat Kumar Dalai. 2020. Ionizing and Non-ionizing Radiation. Ionizing and Non-ionizing Radiation.
Roos M. Jong, Surafel K. Tebeje, Lisette Meerstein‐Kessel, Fitsum G. Tadesse, Matthijs M. Jore, Will Stone & Teun Bousema. (2019) Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites . Immunological Reviews 293:1, pages 190-215.
Crossref
David Ricardo Salamanca, Marcela Gómez, Anny Camargo, Laura Cuy-Chaparro, Jessica Molina-Franky, César Reyes, Manuel Alfonso Patarroyo & Manuel Elkin Patarroyo. (2019) Plasmodium falciparum Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines. Frontiers in Microbiology 10.
Crossref
Seong-Kyun Lee, Jin-Hee Han, Ji-Hoon Park, Kwon-Soo Ha, Won Sun Park, Seok-Ho Hong, Sunghun Na, Yang Cheng & Eun-Taek Han. (2019) Evaluation of antibody responses to the early transcribed membrane protein family in Plasmodium vivax. Parasites & Vectors 12:1.
Crossref
José Antonio Garrido-Cardenas, Lilia González-Cerón, Francisco Manzano-Agugliaro & Concepción Mesa-Valle. (2018) Plasmodium genomics: an approach for learning about and ending human malaria. Parasitology Research 118:1, pages 1-27.
Crossref
Danielle I. Stanisic & Michael F. Good. 2019. Encyclopedia of Malaria. Encyclopedia of Malaria 1 22 .
Rajeev K. Tyagi, Nikunj Tandel, Richa Deshpande, Robert W. Engelman, Satish D. Patel & Priyanka Tyagi. (2018) Humanized Mice Are Instrumental to the Study of Plasmodium falciparum Infection. Frontiers in Immunology 9.
Crossref
Sneha Dutta, Aneesha Tewari, Chinthapalli Balaji, Reena Verma, Anasuya Moitra, Mamta Yadav, Prakhar Agrawal, Dinkar Sahal & Gotam K. Jarori. (2018) Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase. Malaria Journal 17:1.
Crossref
So Jung An, Puthupparampil V. Scaria, Beth Chen, Emma Barnafo, Olga Muratova, Charles Anderson, Lynn Lambert, Myung Hwa Chae, Jae Seung Yang & Patrick E. Duffy. (2018) Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever. Vaccine 36:21, pages 2978-2984.
Crossref
Hirokazu Sakamoto, Satoru Takeo, Eizo Takashima, Kazutoyo Miura, Bernard N. Kanoi, Takamasa Kaneko, Eun-Taek Han, Mayumi Tachibana, Kazuhiro Matsuoka, Jetsumon Sattabongkot, Rachanee Udomsangpetch, Tomoko Ishino & Takafumi Tsuboi. (2018) Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission. Parasitology International 67:2, pages 203-208.
Crossref
J. N. Dinga, S. D. Gamua, S. M. Ghogomu & V. P. K. Titanji. (2018) Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum UB05-09 antigen could be a malaria vaccine candidate . Parasite Immunology 40:3, pages e12514.
Crossref
Puthupparampil V. Scaria, Beth Chen, Christopher G. Rowe, David S. Jones, Emma Barnafo, Elizabeth R. Fischer, Charles Anderson, Nicholas J. MacDonald, Lynn Lambert, Kelly M. Rausch, David L. Narum & Patrick E. Duffy. (2017) Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity. PLOS ONE 12:12, pages e0190312.
Crossref
. (2017) malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication. PLOS Medicine 14:11, pages e1002455.
Crossref
Dylan S Small, Terrie E Taylor, Douglas G Postels, Nicholas AV Beare, Jing Cheng, Ian JC MacCormick & Karl B Seydel. (2017) Evidence from a natural experiment that malaria parasitemia is pathogenic in retinopathy-negative cerebral malaria. eLife 6.
Crossref
Masayuki Morita, Eizo Takashima, Daisuke Ito, Kazutoyo Miura, Amporn Thongkukiatkul, Ababacar Diouf, Rick M. Fairhurst, Mahamadou Diakite, Carole A. Long, Motomi Torii & Takafumi Tsuboi. (2017) Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate. Scientific Reports 7:1.
Crossref
Vikash K. Mishra, Mitali Mishra, Varsha Kashaw & Sushil K. Kashaw. (2017) Synthesis of 1,3,5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents. Bioorganic & Medicinal Chemistry 25:6, pages 1949-1962.
Crossref
Bernard N. Kanoi, Eizo Takashima, Masayuki Morita, Michael T. White, Nirianne M.Q. Palacpac, Edward H. Ntege, Betty Balikagala, Adoke Yeka, Thomas G. Egwang, Toshihiro Horii & Takafumi Tsuboi. (2017) Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda. Vaccine 35:6, pages 873-881.
Crossref
Mohamed A. Dkhil, Saleh A. Al-Quraishy, Abdel-Azeem S. Abdel-Baki, Denis Delic & Frank Wunderlich. (2017) Differential miRNA Expression in the Liver of Balb/c Mice Protected by Vaccination during Crisis of Plasmodium chabaudi Blood-Stage Malaria. Frontiers in Microbiology 7.
Crossref
Alexander D. Douglas. 2017. Malaria. Malaria 211 238 .
Masanori Yagi, Nirianne M. Q. Palacpac, Kazuya Ito, Yuko Oishi, Sawako Itagaki, Betty Balikagala, Edward H. Ntege, Adoke Yeka, Bernard N. Kanoi, Osbert Katuro, Hiroki Shirai, Wakaba Fukushima, Yoshio Hirota, Thomas G. Egwang & Toshihiro Horii. (2016) Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda. Scientific Reports 6:1.
Crossref
Saleh A. Al-Quraishy, Mohamed A. Dkhil, Abdel-Azeem A. Abdel-Baki, Denis Delic & Frank Wunderlich. (2016) Protective Vaccination against Blood-Stage Malaria of Plasmodium chabaudi: Differential Gene Expression in the Liver of Balb/c Mice toward the End of Crisis Phase. Frontiers in Microbiology 7.
Crossref